Introduction: The Shift Toward Decentralized Urological Care
The management of Benign Prostatic Hyperplasia (BPH) has traditionally relied on objective assessments performed within the confines of a clinical setting. Among these, uroflowmetry—the measurement of the rate of urine flow over time—remains a cornerstone for diagnosing bladder outlet obstruction (BOO) and evaluating the success of surgical interventions like Transurethral Resection of the Prostate (TURP). However, conventional in-office uroflowmetry is often fraught with limitations, including the ‘white coat’ effect, where patients feel pressured to void on command, and the ‘snapshot’ nature of a single measurement that may not reflect a patient’s true diurnal voiding patterns.
For patients undergoing TURP, accurate longitudinal monitoring is essential to detect early complications such as acute urinary retention or to confirm the resolution of obstructive symptoms. The burden of frequent clinic visits for uroflowmetry can be prohibitive for elderly patients or those living in remote areas. This has spurred interest in telemedicine and digital health solutions. While various home-monitoring tools have been proposed, few have undergone rigorous, prospective validation in the perioperative period until now.
